GBT Pharma has been appointed to secure new business affiliations for two of Refarmed Chemical’s pharmaceutical brands across Latin America.
Innovators in the global pharmaceutical industry for over 40 years, Refarmed’s portfolio of products includes both APIs and finished formulations.
GBT Pharma – specialists in driving international market entry for consumer healthcare companies – has been appointed to identify and secure key distributor partnerships specifically for Refarmed’s Astarte women’s health probiotic food supplement, and their Bacterial Lysate formulation.
Dr Fabio Gatti from Refarmed Chemicals comments: “GBT Pharma’s understanding of the regulatory requirements and their strong network of contacts in this territory made them the ideal partner to introduce these particular brands in this region.”
GBT Pharma founder Gian Trepp added: “Our mission is to identify and secure suitable partners for these high calibre products across Brazil, Columbia, Peru, Chile, Panama, Costa Rica and Ecuador.
“We invite parties interested in securing these particular pharmaceutical registration dossiers together with supply agreements to contact us at GBT Pharma.”
For further information on GBT Pharma or opportunities with the Refarmed brands in Latin America, please contact us. www.gbtpharma.com/contact-us